Occupational Exposures Among Nurses Caring for Chemotherapy Patients: Quantitative Analysis of Cyclophosphamide and Alpha-Fluoro-Beta-Alanine in Urine
January 2016
in “
SANGYO EISEIGAKU ZASSHI
”
Studysummary This study found that nearly all nurses caring for chemotherapy patients showed detectable levels of cyclophosphamide in their urine, indicating significant occupational exposure to this antineoplastic drug.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study assessed occupational exposure to antineoplastic drugs among 10 female nurses by measuring cyclophosphamide (CP) and α-fluoro-β-alanine (FBAL) in urine. CP was detected in 9 nurses, with levels from 5.4 to 44.2 ng/24-hours, while FBAL was not found. CP presence in nurses not directly handling CP drips suggested exposure through inhalation or dermal absorption. The study emphasized the need for proper personal protective equipment and regular monitoring to reduce exposure risks, noting hair loss as a common health issue among the nurses.